FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
Settlement will drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly The Federal Trade Commission secured a settlement agreement with one of the nation’s largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission’s fight to lower healthcare costs for Americans. View Press Release
Record details
Published: 14 July 2026
Source: US FTC Press Releases
Category: Policy
Topics: Healthcare · Transparency · Biotech
Retrieved: 15 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
FTC Approves Final Order Against TruHeight for Deceptive and Unsubstantiated Advertising of Supplements for Kids and Teens
US FTC Press Releases · 15 July 2026
FTC Secures $12 Million in Penalties for Pre-Merger Reporting Act Violations
US FTC Press Releases · 13 July 2026
Statements on the Grant of Early Termination of the FTC’s Investigation of IonQ’s Proposed Acquisition of SkyWater
US FTC Press Releases · 31 July 2026
Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push
Above the Law (legal tech) · 11 August 2026
Explainable Multi-Task Retinal Imaging Reveals Microvascular Signals for Systemic Risk Stratification in Type 2 Diabetes: A Pilot Study
arXiv · 24 May 2026
An explainable hypothesis-driven approach to Drug-Induced Liver Injury with HADES
arXiv · 4 May 2026
How to cite this record
ethics.ai (14 July 2026), “FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman,” evidence record 10373, https://ethics.ai/record/10373 (originally published by US FTC Press Releases).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.